T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves.
Wallby L, Janerot-Sjöberg B, Steffensen T, Broqvist M.
Heart. 2002 Oct;88(4):348-51. doi: 10.1136/heart.88.4.348.
Mitral stenosis in a teenager after rheumatic mitral valve regurgitation valve repair: A case report.
Ngardig Ngaba N, Chibuzo UN, Patel M, Gulati A, Ola O, Djindimadje A, Khan IA.
Front Cardiovasc Med. 2022 Dec 15;9:978874. doi: 10.3389/fcvm.2022.978874. eCollection 2022.
Prevalence and predictors of non-rheumatic valvular heart disease in patients with sickle cell disease: insights from the National In-Patient Database in 2016 and 2017.
Quelal K, Torres A, Shahi A, Almani MU, Yadav N.
J Investig Med. 2023 Jun;71(5):489-494. doi: 10.1177/10815589231162525. Epub 2023 Mar 21.
Aortic valve repair with patch in non-rheumatic disease: indication, techniques and durability.
Mosala Nezhad Z, de Kerchove L, Hechadi J, Tamer S, Boodhwani M, Poncelet A, Noirhomme P, Rubay J, El Khoury G.
Eur J Cardiothorac Surg. 2014 Dec;46(6):997-1005; discussion 1005. doi: 10.1093/ejcts/ezu058. Epub 2014 Mar 11.
Underlying Rheumatic Disease: An Important Determinant of Outcome in Tricuspid Valve Repair.
Munasur M, Naidoo D.
J Heart Valve Dis. 2016 Mar;25(2):203-210.
Clinical outcomes and progression rate of tricuspid regurgitation in patients with rheumatic mitral valve disease.
Caldas MMC, Esteves WAM, Nascimento BR, Hung J, Levine R, Silva VR, Castro ML, Chavez LMT, Silva JLPD, Mello LA, Ruffo FC, Andrade AB, Tan T, Passaglia LG, Freire CMV, Nunes MCP.
Open Heart. 2023 Sep;10(2):e002295. doi: 10.1136/openhrt-2023-002295.
Prevalence of Coronary Artery Disease in Patients Undergoing Valvular Heart Surgery.
Ren C, Yu J, Zhang J, Wang S, Zhu E, Guo H, Sun D, Tang B, Cui H, Lai Y.
Heart Surg Forum. 2023 Mar 3;26(2):E141-E147. doi: 10.1532/hsf.5331.
Valvular heart disease: the influence of changing etiology on nosology.
Boudoulas H, Vavuranakis M, Wooley CF.
J Heart Valve Dis. 1994 Sep;3(5):516-26.
Percutaneous balloon valvuloplasty for concurrent mitral, aortic and tricuspid rheumatic stenosis.
Sobrino N, Calvo Orbe L, Merino JL, Peinado R, Mate I, Rico J, Garcia Garcia J, Sobrino JA.
Eur Heart J. 1995 May;16(5):711-3. doi: 10.1093/oxfordjournals.eurheartj.a060979.
Effect of Pulmonary Hypertension on Clinical Outcomes in Patients With Rheumatic Mitral Stenosis.
Kim DJ, Lee S, Joo HC, Lee H, Park B, Youn YN, Yoo KJ, Lee SH.
Ann Thorac Surg. 2020 Feb;109(2):496-503. doi: 10.1016/j.athoracsur.2019.05.077. Epub 2019 Jul 20.
